isoxsuprine has been researched along with Erythroblastosis Fetalis in 2 studies
Isoxsuprine: A beta-adrenergic agonist that causes direct relaxation of uterine and vascular smooth muscle. Its vasodilating actions are greater on the arteries supplying skeletal muscle than on those supplying skin. It is used in the treatment of peripheral vascular disease and in premature labor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Van Iddekinge, B | 1 |
| Hughes, EA | 1 |
| Reynolds, JW | 1 |
1 review available for isoxsuprine and Erythroblastosis Fetalis
| Article | Year |
|---|---|
The use of drugs in influencing human fetal metabolism.
Topics: Adrenocortical Hyperfunction; Animals; Blood Transfusion, Intrauterine; Congenital Hypothyroidism; E | 1974 |
1 other study available for isoxsuprine and Erythroblastosis Fetalis
| Article | Year |
|---|---|
The effect of intrauterine fetal transfusion and a beta-sympathomimetic substance on the lecithin/sphingomyelin ratio in human amniotic fluid.
Topics: Amniotic Fluid; Blood Transfusion, Intrauterine; Erythroblastosis, Fetal; Female; Gestational Age; H | 1977 |